Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Exactech, Intuitive, Scopio, Simbiosys, Synchrony.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adcentrx, Atsena, Connect, Eli Lilly, Iaso, Simcere, Trethera.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aktiia, Boston Scientific, Clearnote, Morphic, Q'Apel, W.L. Gore.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Eton, Fujifilm, Humacyte, Immunitybio, Jiangsu Hengrui, Johnson & Johnson, Norgine, Novaliq, Novartis, Zyversa.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Fziomed, Insightec.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Allurion, Astrazeneca, Denali, Kalvista, Lexeo, Mustang, Nurix.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Biocon, Dizal, Hutchmed, Mesoblast, Takeda.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Boston Scientific, Morphic Medical, Sirtex Medical, Thermo Fisher Scientific.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Apotex, Biocon, Dizal, Johnson & Johnson, OS Therapies, Regeneron.